Walleye Capital
AMGN icon

Walleye Capital’s Amgen AMGN Stock Holding History

Walleye Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.8K Sell
25
-9,889
-100% -$3.53M ﹤0.01% 4167
2025
Q4 		$3.24M Sell
9,914
-5,239
-35% -$1.66M 0.01% 1480
2025
Q3 		$4.28M Buy
15,153
+11,783
+350% +$3.42M 0.02% 1022
2025
Q2 		$941K Sell
3,370
-2,910
-46% -$824K ﹤0.01% 2100
2025
Q1 		$1.96M Sell
6,280
-27,924
-82% -$8.25M 0.01% 1431
2024
Q4 		$8.91M Buy
34,204
+23,970
+234% +$7.11M 0.02% 706
2024
Q3 		$3.3M Sell
10,234
-9,738
-49% -$3.19M 0.01% 1496
2024
Q2 		$6.24M Sell
19,972
-24,186
-55% -$7.11M 0.01% 1123
2024
Q1 		$12.6M Buy
+44,158
New +$12.9M 0.02% 695
2021
Q4 		– Sell
-3,700
Closed -$787 – 2082
2021
Q3 		$787 Buy
+3,700
New +$852K 0.02% 569
2020
Q2 		– Sell
-310
Closed -$62K – 604
2020
Q1 		$62K Sell
310
-500
-62% -$109K 0.01% 664
2019
Q4 		$195K Buy
810
+130
+19% +$28.7K 0.01% 1124
2019
Q3 		$132K Buy
680
+280
+70% +$53.7K 0.01% 1346
2019
Q2 		$74K Buy
+400
New +$71.6K 0.01% 1300

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Walleye Capital's AMGN Position: Q1 2026 in Review

Walleye Capital reduced its Amgen (AMGN) stake by 100% in Q1 2026, selling an estimated $3.53M and leaving 25 shares worth $8.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4167.

Walleye Capital first reported a position in AMGN in Q2 2019 and has held it in 14 quarters since. The position peaked at $12.6M in Q1 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Walleye Capital held 25 shares of Amgen worth $8.8K as of Q1 2026.
  • Walleye Capital sold 9,889 Amgen shares in Q1 2026, an estimated $3.53M.
  • Amgen made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4167 holding.
  • Walleye Capital first reported a position in Amgen in Q2 2019 and has held it in 14 quarters since.
  • Walleye Capital's Amgen position peaked at $12.6M in Q1 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.